コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ad cardiac enzyme elevations consistent with non-ST segment elevation myocardial infarction.
2 and separately for ST-segment elevation and non-ST-segment elevation myocardial infarction.
3 ronary syndromes include unstable angina and non-ST-segment elevation myocardial infarction.
4 evascularization in patients presenting with non-ST-segment elevation myocardial infarction.
5 ces in treatment strategies in patients with non-ST-segment elevation myocardial infarction.
6 myocardial damage after PCI in patients with non-ST-segment elevation myocardial infarction.
7 coronary intervention (PCI) in patients with non-ST-segment elevation myocardial infarction.
8 l infarction and a lower rate of death after non-ST-segment elevation myocardial infarction.
9 terns among these patients in the setting of non-ST-segment-elevation myocardial infarction.
10 h, and hospitalized ST-segment-elevation and non-ST-segment-elevation myocardial infarction.
11 rtery bypass surgery (CABG) in patients with non-ST-segment-elevation myocardial infarction.
12 sibility of FFR measurement in patients with non-ST-segment-elevation myocardial infarction.
13 on early and late outcomes in patients with non-ST-segment-elevation myocardial infarction.
14 on mortality, specifically, in patients with non-ST-segment-elevation myocardial infarction.
15 tion myocardial infarction, 103,245 [20.6%]; non-ST-segment elevation myocardial infarction, 105,708
16 atelet Effects of AZD6140 vs. clopidogRel in non-ST-segment Elevation myocardial infarction)-2, we co
17 segment elevation myocardial infarction; 38% non-ST-segment elevation myocardial infarction; 6% unsta
18 ocardial infarction and 87,915 patients with non-ST-segment elevation myocardial infarction, 88,542 (
19 ked detailed clinical data for patients with non-ST-segment-elevation myocardial infarction aged >/=6
21 evascularization strategies in patients with non-ST-segment elevation myocardial infarction and multi
22 ase, glaucoma, lower urinary tract symptoms, non-ST-segment elevation myocardial infarction and unsta
23 utaneous coronary intervention for elective, non-ST-segment-elevation myocardial infarction and ST-se
24 younger age categories and in patients with non-ST-segment-elevation myocardial infarction and stabl
25 (PCI) in the United States for patients with non-ST-segment-elevation myocardial infarction and the c
26 for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and seco
27 s three clinical diagnoses: unstable angina, non-ST-segment elevation myocardial infarction), and ST-
28 elevation myocardial infarction, 35.6% with non-ST-segment elevation myocardial infarction, and 23.6
31 diagnosis, and treatment of unstable angina/non-ST-segment elevation myocardial infarction are revie
32 0.30; 95% CI: -0.98 to 1.58; p = 0.637) and non-ST-segment elevation myocardial infarction (ATE coef
33 patients underwent CABG within 21 days after non-ST-segment-elevation myocardial infarction between J
34 hs-cTn concentrations even in the absence of non-ST-segment elevation myocardial infarction, concern
36 evel analysis of 105,383 patients with acute non-ST-segment elevation myocardial infarction enrolled
37 rmed by 9254 operators at 1538 hospitals for non-ST-segment-elevation myocardial infarction from 2009
38 , or transfusion) among 99 200 patients with non-ST-segment elevation myocardial infarction in the Na
39 ortion of coronary care unit admissions with non-ST-segment elevation myocardial infarction increased
42 ponin is a sensitive biomarker to "rule out" non-ST-segment elevation myocardial infarction, it is le
44 ients experienced serious adverse events: 1) non-ST-segment elevation myocardial infarction (MI) 8 h
45 convention in acute coronary syndrome (ACS)/non-ST-segment elevation myocardial infarction (MI) in t
46 management is recommended for patients with non-ST-segment elevation myocardial infarction (MI), but
47 total of 17,421 patients with ACS (including non-ST-segment elevation myocardial infarction [MI], ST-
48 artery disease (FFR</=0.8) in patients with non-ST-segment-elevation myocardial infarction (n=21) wh
50 myocardial infarction (n=5996, 853 deaths), non-ST-segment-elevation myocardial infarction (n=5371,
51 l disease presenting with unstable angina or non-ST-segment elevation myocardial infarction (non-ST-s
52 re older than 18 years with unstable angina, non-ST segment elevation myocardial infarction (NSTEMI)
53 influenced hospitals' care or outcomes among non-ST-segment elevation myocardial infarction (NSTEMI)
54 h for patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI)
55 el in patients with unstable angina (UA) and non-ST-segment elevation myocardial infarction (NSTEMI)
56 Risk stratification in unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI)
57 tcomes in patients with unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI)
58 here are no trials assessing thrombectomy in non-ST-segment elevation myocardial infarction (NSTEMI)
59 nt oral p38 MAPK inhibitor, in patients with non-ST-segment elevation myocardial infarction (NSTEMI)
60 Elderly patients mostly (71%) presented with non-ST-segment elevation myocardial infarction (NSTEMI),
61 link in CD4(+) T cells from 20 patients with non-ST-segment elevation myocardial infarction (NSTEMI),
62 percutaneous coronary intervention (PCI) for non-ST-segment elevation myocardial infarction (NSTEMI),
63 ents with elective PCI, unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI),
64 high-risk patients with unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI).
65 terize the risk of death among patients with non-ST-segment elevation myocardial infarction (NSTEMI).
66 arkers in patients with unstable angina (UA)/non-ST-segment elevation myocardial infarction (NSTEMI).
67 th UFH in the management of unstable angina/ non-ST-segment elevation myocardial infarction (NSTEMI).
68 s for the care and outcomes of patients with non-ST-segment elevation myocardial infarction (NSTEMI).
69 mized clinical trial involving patients with non-ST-segment elevation myocardial infarction (NSTEMI).
70 anaged patients with unstable angina (UA) or non-ST-segment elevation myocardial infarction (NSTEMI).
71 change in troponin T levels in patients with non-ST-segment elevation myocardial infarction (NSTEMI).
74 -elevation myocardial infarction (STEMI) and non-ST-segment-elevation myocardial infarction (NSTEMI)
76 of fractional flow reserve in patients with non-ST-segment-elevation myocardial infarction (NSTEMI)
77 me and endothelial function in patients with non-ST-segment-elevation myocardial infarction (NSTEMI)
78 endation for medically managed patients with non-ST-segment-elevation myocardial infarction (NSTEMI).
79 vation myocardial infarction [STEMI] and 241 non-ST-segment elevation myocardial infarction [NSTEMI]
80 Non-ST-segment-elevation myocardial infarctions occurred
81 ; 95% confidence interval: 2.92 to 3.06) and non-ST-segment elevation myocardial infarction (odds rat
82 ssel coronary artery disease presenting with non-ST-segment-elevation myocardial infarction, only one
83 (ST-segment elevation myocardial infarction, non-ST-segment elevation myocardial infarction, or unsta
84 ogrel treatment platelet reactivity (HPR) in non-ST-segment elevation myocardial infarction patients
85 bciximab with UFH versus bivalirudin treated non-ST-segment elevation myocardial infarction patients
88 Medicare claims from 2003 to 2006 for 25 872 non-ST-segment-elevation myocardial infarction patients
91 tterns of early antithrombotic treatment for non-ST-segment-elevation myocardial infarction patients
92 e postdischarge treatment of unstable angina/non-ST-segment-elevation myocardial infarction patients.
93 therapy among therapeutically anticoagulated non-ST-segment-elevation myocardial infarction patients.
94 or overweight and obese older patients after non-ST-segment-elevation myocardial infarction relative
95 Patients (N = 544) with non-ST-segment elevation myocardial infarction scheduled
97 -segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction, signific
98 adoxically lower in-hospital mortality after non-ST-segment-elevation myocardial infarction than thei
100 esentations ranging from unstable angina and non-ST-segment elevation myocardial infarction to ST-seg
101 nselected patients presenting with suspected non-ST-segment elevation myocardial infarction to the em
102 ative analysis of bivalirudin versus UFH for non-ST-segment-elevation myocardial infarction to date,
104 care and outcomes among 40 500 patients with non-ST-segment-elevation myocardial infarction treated a
105 PPI agents in patients with unstable angina/non-ST-segment-elevation myocardial infarction treated w
106 We analyzed 10 095 consecutive patients with non-ST-segment-elevation myocardial infarction treated w
107 nt At the time of diagnosis in patients with non-ST-segment elevation myocardial infarction) trial, 4
108 utcomes in patients with unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEM
109 SPS) in patients with recent unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEM
110 inhibitors are beneficial in unstable angina/non-ST-segment elevation myocardial infarction (UA/NSTEM
111 ial, patients with either unstable angina or non-ST-segment elevation myocardial infarction (UA/NSTEM
112 ognosis in patients with unstable angina and non-ST-segment elevation myocardial infarction (UA/NSTEM
113 ts in treating patients with unstable angina/non-ST-segment elevation myocardial infarction undergoin
114 antation in patients with unstable angina or non-ST-segment elevation myocardial infarction undergoin
115 er protection against AKI in patients with a non-ST-segment elevation myocardial infarction undergoin
116 acute kidney injury (AKI) in patients with a non-ST-segment elevation myocardial infarction undergoin
117 udin and heparin plus a GPI in patients with non-ST-segment elevation myocardial infarction undergoin
118 mal antithrombotic therapy for patients with non-ST-segment elevation myocardial infarction undergoin
119 ed 3798 clopidogrel-pretreated patients with non-ST-segment elevation myocardial infarction undergoin
120 in IIb/IIIa inhibitor (GPI) in patients with non-ST-segment elevation myocardial infarction undergoin
121 Non-ST-segment elevation myocardial infarctions undetect
122 dergoing PCI for STEMI or other indications (non-ST-segment-elevation myocardial infarction, unstable
123 gment-elevation myocardial infarction versus non-ST-segment-elevation myocardial infarction/unstable
124 algorithm for rapid rule-out and rule-in of non-ST-segment elevation myocardial infarction using hig
126 -segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction were cons
127 ts with medically managed unstable angina or non-ST-segment elevation myocardial infarction were enro
128 The case of Mr C, a 43-year-old man with non-ST-segment elevation myocardial infarction, which is
129 , 30 patients with either unstable angina or non-ST segment elevation myocardial infarction who had r
130 rization) in diabetes mellitus patients with non-ST-segment-elevation myocardial infarction who had a
132 -eluting stent implantation in patients with non-ST-segment-elevation myocardial infarction would pro
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。